Analyst Ratings January 23, 2026

Jefferies Assigns Hold to Terna, Highlights Valuation Concerns Despite Solid Fundamentals

Italian Grid Leader Faces Elevated Market Valuation Amid Infrastructure Expansion

By Maya Rios TRN
Jefferies Assigns Hold to Terna, Highlights Valuation Concerns Despite Solid Fundamentals
TRN

Jefferies has initiated coverage on Terna Rete Elettrica Nazionale SpA with a Hold rating and set a price target of €9.80, pointing to stretched valuation levels even as the company benefits from a strong regulatory environment and robust growth in its regulated asset base driven by Italy's energy transition investments.

Key Points

  • Terna commands a higher return on equity than European peers due to a favorable regulatory framework, averaging about 14% ROE over the past five years compared to competitors' 9%.
  • The company’s regulated asset base is projected to grow at approximately 9% CAGR through 2029, supported by Italy’s substantial €18 billion plan to facilitate the energy transition.
  • Earnings per share growth is anticipated to be limited to 5.5% annually through 2029 due to rising depreciation and financial costs, which will offset top-line expansion.

Investment firm Jefferies has begun covering Terna Rete Elettrica Nazionale SpA (BIT:TRN), Italy's leading electricity grid operator, with a Hold recommendation and a target price of €9.80. The cautious stance reflects concerns about the current premium valuation of the stock, despite the company's attractive growth prospects and a supportive regulatory framework.

Terna operates within a regulatory system that affords it higher allowed returns than most European peers, leading to an impressive average return on equity (ROE) near 14% over the last five years. This compares favorably to a typical ROE around 9% among its European counterparts. The company has effectively maintained a positive spread above its regulated return by roughly 250 basis points, a trend that Jefferies anticipates will persist going forward.

Looking ahead, Jefferies anticipates that Terna's Regulated Asset Base (RAB)—the value of its assets subject to regulation—will expand at a compound annual growth rate (CAGR) of about 9% through 2029. This growth is fueled by Italy’s substantial €18 billion investment program targeting the nation’s energy transition efforts.

However, earnings per share (EPS) growth is forecasted to be more modest, projected at 5.5% annually through the same period. This is partly due to anticipated increases in depreciation costs and financing expenses that will weigh on profitability.

Regarding Terna’s financial structure, Jefferies expresses some caution. The firm projects the company’s Net Debt to EBITDA ratio will climb from near 5.0 times in fiscal year 2025 to approximately 6.0 times by fiscal year 2029. While the existing financial position is deemed adequate to support Terna's upcoming investments, there is a potential need for an additional €3.5 billion in capital if investment outlays exceed current plans, which could constrain financial flexibility.

From a valuation standpoint, Terna’s shares currently trade at a significant premium—around 20% above the FY27 RAB—surpassing the historic average spread of 15%. Moreover, the company commands a price-to-earnings (P/E) ratio of 16.7 times for fiscal year 2026 and possesses a price/earnings-to-growth (PEG) ratio of 3.0 for 2026-2029, figures that are elevated relative to other regulated utilities.

Risks

  • Terna’s Net Debt/EBITDA ratio is forecasted to rise from about 5.0x in FY25 to approximately 6.0x in FY29, potentially pressuring the balance sheet as investment needs increase.
  • There could be a requirement for up to €3.5 billion in additional financing beyond plan if capital expenditures surpass current estimates, potentially reducing financial flexibility.
  • The current valuation premium over historical averages and peers introduces a market risk if growth or regulatory conditions change, potentially affecting share price negatively.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026